RIABNI vs VUMON

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. RIABNI and VUMON are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	RIABNI	VUMON
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	RITUXIMAB-ARRX	TENIPOSIDE
Manufacturer	Amgen Inc	Hq Speclt Pharma
Dosage forms	Injectable	Injectable
Drug class	—	—
Boxed warning	Boxed warning	None
Treats	Rheumatoid Arthritis, Lymphoid Leukemia, Granulomatosis with Polyangiitis	Lymphoid Leukemia, Lung Neoplasms, Small Cell Carcinoma

riabni vumon

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

RITUXIMAB-ARRX

TENIPOSIDE

Manufacturer

Amgen Inc

Hq Speclt Pharma

Dosage forms

Injectable

Drug class

—

Boxed warning

None

Treats

Rheumatoid Arthritis, Lymphoid Leukemia, Granulomatosis with Polyangiitis

Lymphoid Leukemia, Lung Neoplasms, Small Cell Carcinoma

Frequently asked questions

What is the difference between Riabni and Vumon?

Riabni contains Rituximab-Arrx, while Vumon contains Teniposide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.